Form 4: Molina Healthcare Director Ronna Romney Receives Stock Grant

Molina Healthcare director Ronna Romney was granted 317 shares of common stock as part of her compensation for services.

Summary

• Ronna Romney, a Director of Molina Healthcare, Inc. (MOH), acquired 317 shares of common stock.
• The transaction occurred on January 1, 2026, at a price of $173.54 per share.
• This grant is part of the Issuer's 2025 Equity Incentive Plan, compensating her for director services.
• The annual equity award for directors is $220,000, with $55,000 granted quarterly.
• The share count was based on the closing price of $173.54 on December 31, 2025, as January 1, 2026, was a non-trading day.
• Following this transaction, Ronna Romney beneficially owns 17,733 shares, held indirectly by the Ronna Romney Revocable Trust.

Sentiment

Score: 6

Explanation: The filing reports a routine, expected stock grant to a director as part of their compensation. This is a neutral to slightly positive event as it aligns director interests with shareholders, but does not indicate any significant new developments for the company.

Positives

• Director Ronna Romney received an equity award, aligning her interests with shareholders.
• The grant is part of a pre-established 2025 Equity Incentive Plan, indicating a structured compensation approach.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the scheduled future grant date.

Industry Context

This routine director stock grant is a standard practice in corporate governance across various industries, aligning director incentives with shareholder value. It does not provide specific insights into broader industry trends or competitive positioning.

Comparison to Industry Standards

• Director compensation through equity grants is a common practice among publicly traded companies, including those in the healthcare sector.
• While specific comparable companies or projects are not detailed, the structure of an annual equity award with quarterly grants is a widely adopted method for director remuneration, aiming to align long-term interests.
• Many S&P 500 companies utilize similar equity-based compensation plans for their non-employee directors.

Corporate Governance

Related Party Transactions

• The 17,733 shares beneficially owned by Ronna Romney are held indirectly by the Ronna Romney Revocable Trust, which is a related party.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders, potentially fostering better long-term decision-making. It represents a routine compensation expense.
• Employees: No direct impact on employees is indicated.
• Customers: No direct impact on customers is indicated.
• Suppliers: No direct impact on suppliers is indicated.
• Creditors: No direct impact on creditors is indicated.

Next Steps

• Future quarterly equity awards to directors are expected to continue under the 2025 Equity Incentive Plan.

Key Dates

Recommendation

This Form 4 reports a routine, pre-scheduled equity grant to a director as part of their compensation package. Such a transaction is expected and does not provide new material information that would warrant a change in investment recommendation. It reflects standard corporate governance and compensation practices, aligning director incentives with shareholder value, but does not signal any significant operational or strategic shifts for Molina Healthcare that would alter its investment thesis.

Keywords

Molina Healthcare, MOH, Ronna Romney, Director Compensation, Stock Grant, Equity Incentive Plan, SEC Form 4, Insider Transaction